Abstracts tagged "Early Rheumatoid Arthritis and quality of life"

Abstract Number: 1056 • 2014 ACR/ARHP Annual Meeting
Factors Associated with Impairment on Quality of Life in Early or Established RA Patients
Dam Kim¹, Yoon-Kyoung Sung^2,3, Soo-Kyung Cho^1,3, Soyoung Won¹, Minkyung Han¹, So-Young Bang⁴, Hoon-Suk Cha⁵, Chan-Bum Choi^2,3, Jung-Yoon Choe⁶, Won Tae Chung⁷, Seung-Jae Hong⁸, Jae-Bum Jun³, Young Ok Jung⁹, Jinseok Kim¹⁰, Seong-Kyu Kim¹¹, Tae-Hwan Kim¹², Tae-Jong Kim¹³, Eunmi Koh¹⁴, Choong Ki Lee¹⁵, Hye-Soon Lee¹⁶, Joo-Hyun Lee¹⁷, Jaejoon Lee¹⁸, Jisoo Lee¹⁹, Sang-Heon Lee²⁰, Shin-Seok Lee²¹, Sung Won Lee²², Seung-Cheol Shim²³, Dae-Hyun Yoo², Wan-Hee Yoo²⁴, Bo Young Yoon²⁵ and Sang-Cheol Bae^1,2, ¹Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, ²Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ³Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ⁴Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea, ⁵Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, ⁶Division of Rheumatology, Catholic University of Daegu School of Medicine, Daegu, South Korea, ⁷Dong-A University Hospital, Busan, South Korea, ⁸Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea, ⁹Rheumatology dept, Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, South Korea, ¹⁰Jeju National University Hospital, Jeju, South Korea, ¹¹Catholic University of Daegu School of Medicine, Daegu, South Korea, ¹²Division of Rheumatology, Department of Internal Medicine, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ¹³Chonnam Nat`l University Medical School&Hospital, Gwangju, South Korea, ¹⁴Dept of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, ¹⁵Internal medicine, school of medicine, Yeungnam University, Daegu, South Korea, ¹⁶Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ¹⁷Department of Rheumatology, Ilsan Paik Hospital, Inje University, Goyang, South Korea, ¹⁸Division of Rheumatology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, ¹⁹Ewha Womans University School of Medicine, Seoul, South Korea, ²⁰Dept of Internal Medicine, Konkuk University Hospital, Seoul, South Korea, ²¹Division of, Chonnam National University Med School, Gwangju, South Korea, ²²Dong-A university,Busan, South Korea, Pusan, South Korea, ²³Chungnam National University Hospital, Daejeon, South Korea, ²⁴Division of Rheumatology, Department of Internal Medicine, Chonbuk National University School of Medicine, Jeonju, South Korea, ²⁵Inje University Ilsan Paik Hospital, Goyang, South Korea
Background/Purpose Rheumatoid arthritis (RA) is a chronic inflammatory disabling disease with significant impact on the quality of life (QOL) of patients. Since clinical features are…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].